secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPLASH BEVERAGE GROUP, INC. (SBEV)
CIK:        0001553788
Form:       8-K
Filed at:   2026-10-05T20:02:20+00:00
Accession:  0001731122-26-001312
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Endovia's CannEpil for canine bone cancer pain gets FDA 'minor use' status, opening conditional approval path
--------------------------------------------------------------------------------

- FDA's Center for Veterinary Medicine determined CannEpil, an investigational CBD/THC oral solution for pain from bone cancer in dogs, qualifies as a 'minor use' under the MUMS program.
- The determination makes CannEpil eligible for the conditional approval pathway, and FDA said the minor-use status will be maintained through approval of the New Animal Drug Application (NADA).
- Endovia and Lupvindol BioSciences are scheduled to meet FDA on November 19, 2026 for a Pre-Submission Conference on required studies, manufacturing and regulatory submissions.
- The companies are finalizing U.S.-based FDA-compliant manufacturing to support a potential 2027 veterinary commercial launch; CannEpil remains an unapproved investigational new animal drug.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226001312/0001731122-26-001312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553788/000173112226001312/e7991_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-001312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer